ebook img

Coronary Disease in Women: Evidence-Based Diagnosis and Treatment PDF

422 Pages·2004·3.333 MB·English
Save to my drive
Quick download
Download
Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.

Preview Coronary Disease in Women: Evidence-Based Diagnosis and Treatment

C D W ORONARY ISEASE IN OMEN C C ONTEMPORARY ARDIOLOGY CHRISTOPHER P. CANNON, MD SERIES EDITOR Coronary Disease in Women: Evidence-Based Aging, Heart Disease, and Its Management, Diagnosis and Treatment, edited by Leslee Facts and Controversies, edited by Niloo M. J. Shaw, PhD and Rita F. Redberg, MD,FACC, Edwards,MD, Mathew S. Maurer, MD, and 2004 Rachel B. Wellner, MPH, 2003 The Columbia University New York Presbyterian Peripheral Arterial Disease: Diagnosis and Manual of Cardiac Transplantation, edited Treatment,edited by Jay D. Coffman, MD and byNiloo M. Edwards, MD, Jonathan M, Chen, Robert T. Eberhardt, MD, 2003 MD, and Pamela A. Mazzeo, 2004 Primary Angioplasty in Acute Myocardial Heart Disease and Erectile Dysfunction, Infarction,edited by James E. Tcheng, MD, edited by Robert A. Kloner, MD,PhD, 2004 2002 Complementary and Alternative Medicine in Cardiogenic Shock: Diagnosis and Cardiovascular Disease, editedbyRichard Treatment,edited by David Hasdai, MD, Peter A. Stein, MD and Mehmet C. Oz, MD, 2004 B. Berger, MD, Alexander Battler, MD, and Minimally Invasive Cardiac Surgery, Second David R. Holmes, Jr., MD, 2002 Edition,edited by Daniel J. Goldstein and Management of Cardiac Arrhythmias, edited Mehmet C. Oz, MD,MD, 2004 by Leonard I. Ganz, MD, 2002 Nuclear Cardiology, The Basics: How to Set Up Diabetes and Cardiovascular Disease, and Maintain a Laboratory, edited by Frans edited by Michael T. Johnstone and Aristidis J. Th. Wackers, MD,PhD, Wendy Bruni, BS, Veves,MD,DSC, 2001 CNMT, and Barry L. Zaret, MD, 2004 Blood Pressure Monitoring in Cardiovascular Cardiovascular Health Care Economics, Medicine and Therapeutics, edited by edited by William S. Weintraub, MD, 2003 William B. White, MD, 2001 Platelet Glycoprotein IIb/IIIa Inhibitors in Vascular Disease and Injury: Preclinical Cardiovascular Disease, Second Research,edited by Daniel I. Simon, MD, Edition,edited by A. Michael Lincoff, MD, and Campbell Rogers, MD 2001 2003 Preventive Cardiology: Strategies for the Heart Failure:A Clinician's Guide to Prevention and Treatment of Coronary Ambulatory Diagnosis and Treatment, Artery Disease, edited by JoAnne Micale edited by Mariell L. Jessup, MD,FACC,FAHA, Foody,MD, 2001 and Evan Loh, MD,FACC,FAHA, 2003 Nitric Oxide and the Cardiovascular System, Cardiac Repolarization: Bridging Basic and edited by Joseph Loscalzo, MD,PhD, and Clinical Science, edited by Ihor Gussak, MD, Joseph A. Vita, MD, 2000 PhD, Charles Antzelevitch, PhD, Stephen Annotated Atlas of Electrocardiography: C. Hammill, MD,coedited by Win-Kuong A Guide to Confident Interpretation, Shen,MD, and Preben Bjerregaard, MD,DMSc, byThomas M. Blake, MD, 1999 2003 Platelet Glycoprotein IIb/IIIa Inhibitors in Essentials of Bedside Cardiology: With a Cardiovascular Disease,edited by A. Michael Complete Course in Heart Sounds and Lincoff,MD, and Eric J. Topol, MD, 1999 Murmurs on CD, Second Edition, Minimally Invasive Cardiac Surgery,edited by byJules Constant, MD,FACC, 2003 Mehmet C. Oz, MD, and Daniel J. Goldstein, Management of Acute Coronary Syndromes, MD, 1999 Second Edition, edited by Christopher P. Management of Acute Coronary Syndromes, Cannon,MD, 2003 edited by Christopher P. Cannon, MD, 1999 C D ORONARY ISEASE W IN OMEN Evidence-Based Diagnosis and Treatment Edited by L J. S , ESLEE HAW PhD Outcomes Research, American Cardiovascular Research Institute, Atlanta, GA R F. R , , ITA EDBERG MD FACC Division of Cardiology, University of California School of Medicine, San Francisco, CA SPRINGER SCIENCE+BUSINESS MEDIA, LLC © 2004 (cid:54)(cid:83)(cid:85)(cid:76)(cid:81)(cid:74)(cid:72)(cid:85)(cid:3)(cid:54)(cid:70)(cid:76)(cid:72)(cid:81)(cid:70)(cid:72)(cid:14)(cid:37)(cid:88)(cid:86)(cid:76)(cid:81)(cid:72)(cid:86)(cid:86)(cid:3)(cid:48)(cid:72)(cid:71)(cid:76)(cid:68)(cid:3)(cid:49)(cid:72)(cid:90)(cid:3)(cid:60)(cid:82)(cid:85)(cid:78)(cid:3)(cid:3) (cid:50)(cid:85)(cid:76)(cid:74)(cid:76)(cid:81)(cid:68)(cid:79)(cid:79)(cid:92)(cid:3)(cid:83)(cid:88)(cid:69)(cid:79)(cid:76)(cid:86)(cid:75)(cid:72)(cid:71)(cid:3)(cid:69)(cid:92)(cid:3)(cid:43)(cid:88)(cid:80)(cid:68)(cid:81)(cid:68)(cid:3)(cid:51)(cid:85)(cid:72)(cid:86)(cid:86)(cid:3)(cid:44)(cid:81)(cid:70)(cid:17)(cid:3)(cid:76)(cid:81)(cid:3)2004 Softcover reprint of the hardcover 1st edition 2004 All rights reserved. No part of this book may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, microfilming, recording, or otherwise without written permission from the Publisher. The content and opinions expressed in this book are the sole work of the authors and editors, who have warranted due diligence in the creation and issuance of their work. The publisher, editors, and authors are not responsible for errors or omissions or for any consequences arising from the information or opinions presented in this book and make no warranty, express or implied, with respect to its contents. Due diligence has been taken by the publishers, editors, and authors of this book to assure the accuracy of the information published and to describe generally accepted practices. The contributors herein have carefully checked to ensure that the drug selections and dosages set forth in this text are accurate and in accord with the standards accepted at the time of publication. Notwithstanding, as new research, changes in government regulations, and knowledge from clinical experience relating to drug therapy and drug reactions constantly occurs, the reader is advised to check the product information provided by the manufacturer of each drug for any change in dosages or for additional warnings and contraindications. This is of utmost importance when the recommended drug herein is a new or infrequently used drug. It is the responsibility of the treating physician to determine dosages and treatment strategies for individual patients. Further it is the responsibility of the health care provider to ascertain the Food and Drug Administration status of each drug or device used in their clinical practice. The publisher, editors, and authors are not responsible for errors or omissions or for any consequences from the application of the information presented in this book and make no warranty, express or implied, with respect to the contents in this publication. Production Editor: Robin B. Weisberg. Cover design by Patricia F. Cleary This publication is printed on acid-free paper. ∞ ANSI Z39.48-1984 (American National Standards Institute) Permanence of Paper for Printed Library Materials. Photocopy Authorization Policy: Photocopy Authorization Policy: Authorization to photocopy items for internal or personal use, or the internal or personal use of specific clients is granted by (cid:54)(cid:83)(cid:85)(cid:76)(cid:81)(cid:74)(cid:72)(cid:85)(cid:3)(cid:54)(cid:70)(cid:76)(cid:72)(cid:81)(cid:70)(cid:72)(cid:14)(cid:37)(cid:88)(cid:86)(cid:76)(cid:81)(cid:72)(cid:86)(cid:86)(cid:3)(cid:48)(cid:72)(cid:71)(cid:76)(cid:68)(cid:15)(cid:3)(cid:47)(cid:47)(cid:38)(cid:3), provided that the base fee of US $25.00 per copy is paid directly to the Copyright Clearance Center (CCC), 222 Rosewood Dr., Danvers MA01923. For those organizations that have been granted a photocopy license from the CCC, a separate system of payment has been arranged and is acceptable to the (cid:54)(cid:83)(cid:85)(cid:76)(cid:81)(cid:74)(cid:72)(cid:85)(cid:3)(cid:54)(cid:70)(cid:76)(cid:72)(cid:81)(cid:70)(cid:72)(cid:14) (cid:37)(cid:88)(cid:86)(cid:76)(cid:81)(cid:72)(cid:86)(cid:86)(cid:3)(cid:48)(cid:72)(cid:71)(cid:76)(cid:68)(cid:15)(cid:3)(cid:47)(cid:47)(cid:38)(cid:3). 10 9 8 7 6 5 4 3 2 1 ISBN 978-1-61737-275-9 ISBN 978-1-59259-645-4 (eBook) ISBN 10.1007/978-1-59259-645-4 Library of Congress Cataloging-in-Publication Data Coronary disease in women : evidence-based diagnosis and treatment / edited by Leslee J. Shaw and Rita F. Redberg. p. ; cm. -- (Contemporary cardiology) Includes bibliographical references and index. 1. Heart diseases in women. 2. Coronary heart disease. 3. Evidence-based medicine. I. Shaw, Leslee J., 1957– II. Redberg, Rita F. (Rita Fran), 1956– III. Contemporary cardiology (Totowa, N.J. : unnumbered) [DNLM: 1. Coronary Disease--diagnosis. 2. Coronary Disease--therapy. 3. Evidence-Based Medicine. 4. Sex Factors. 5. Women's Health. WG 300 C82173 2004] RC685.C6C635 2004 616.1'2'0082--dc21 2003049990 P REFACE Coronary Disease in Women: Evidence-Based Diagnosis and Treatment provides a clinical management approach to the care of women with known or suspected coronary artery disease. Whereas previous books on the subject have focused on gender-based differences in the epidemiology of coronary disease as well as in gender bias in treatment, this text focuses on the daily clinical management of women using an evidence-based approach. Because women’s health is also a critical issue to health care administrators, an increas- ingly important decision maker in health care, additional chapters address managing women’s health issues in our current era of managed care and organizing a women’s health center. Topical issues on the effectiveness of using a gynecologist to diagnose or manage coronary disease, as well as the cost effectiveness of diagnosis and treatment are also included. In the current health care era, there is an increased use of guidelines or pathways of care that are developed within managed care organizations to deal with coronary artery dis- ease.Coronary Disease in Women includes special management issues with women in developing clinical pathways, including those of primary and secondary prevention of coronary heart disease. Primary care physicians, including cardiologists, family practi- tioners, and general internists should find this text both informative and timely. ACKNOWLEDGMENT We would like to thank Lesley Wood, MA, for her editorial assistance with this book. Leslee J. Shaw, PhD Rita F. Redberg, MD,FACC v C ONTENTS Preface............................................................................................................................v Contributors...................................................................................................................xi P I. I ART NTRODUCTION 1 The Institute of Medicine Report, Women’s Cardiovascular Health, and Evidence-Based Medicine........................................3 Nanette K. Wenger 2 Evidence-Based Medicine in the Assessment of Women at Risk for Cardiovascular Disease..............................................9 Leslee J. Shaw P II. S D C D W ART CREENING AND IAGNOSIS OF ORONARY ISEASE IN OMEN A. Cardiovascular Epidemiology in Women 3 Population-Based Sex Differences in Disease Incidence and Prevalence............................................................................19 Brandi J. Witt and Véronique L. Roger 4 Risk Detection and Primary Prevention in Women.......................29 Lori Mosca and Leslee J. Shaw 5 Early Detection of Coronary Artery Disease in Women: Role of Coronary Artery Calcium Scanning With EBT.............47 John A. Rumberger 6 Heart Failure in Women: Epidemiology, Gender Differences in Pathophysiology, and Implications for Therapy...................65 Daniel P. Morin, Marvin A. Konstam, Michael E. Mendelsohn, and James E. Udelson 7 Diastolic Dysfunction in Women...................................................93 Mary Norine Walsh and Mariell Jessup 8 Functional Capacity and Activities of Daily Living in Women..................................................................................103 Claire E. Pothier Snader and Michael S. Lauer 9 Special Considerations for Minority Women ..............................119 Jennifer H. Mieres and Elizabeth Ofili B. Varying Symptom Presentation in Women 10 Clinical Risk Assessment in Women: Chest Discomfort. Report from the WISE Study.....................................................129 B. Delia Johnson, Sheryl F. Kelsey, and C. Noel Bairey Merz 11 Quality-of-Life Issues for Women With Coronary Disease........143 John Spertus and Darcy Green-Conaway vii viii Contents C. Choosing the Best Diagnostic Test for Women 12 Should All Women With Suspected Coronary Disease Undergo Stress Cardiac Imaging?............................................161 Anthony P. Morise 13 State-of-the-Art Diagnostic Testing in Women: A Research Update...................................................................173 Leslee J. Shaw, B. Delia Johnson, Sharon Mulvagh, Jennifer H. Mieres, Rita F. Redberg, and C. Noel Bairey Merz P III. M C D W ART ANAGEMENT OF ORONARY ISEASE IN OMEN A. Evaluation of Stable Chest Pain Syndromes in Women 14 Treatment Strategies for Women With Stable Angina................197 Paul R. Casperson, Leslee J. Shaw, and Robert A. O’Rourke 15 Improving the Diagnosis and Management of Women With Coronary Disease in Primary Care Settings ...................215 Kimberly J. Rask B. Evaluation of Acute Ischemic Syndromes in Women 16 Evaluation of Acute Chest Pain in Women..................................227 Andra L. Blomkalns, W. Brian Gibler, and L. Kristin Newby 17 Acute Ischemic Syndromes: Differences in Presentation and Treatment in Women .........................................................243 Jane A. Leopold and Alice K. Jacobs C. Variations in Therapeutic Effectiveness in Women 18 Effectiveness of Coronary Revascularization: Gender and Racial Differences................................................269 Christi Deaton, Cherie L. Kunik, and Eric Peterson 19 Electrophysiology:Treatment Considerations in Women...........285 Michael S. Bailey and Anne B. Curtis 20 Exercise Training and Cardiac Rehabilitation for Women..........297 Elisa Yuen Man Chiu, Maria Vivina T. Regis, and Erika Sivarajan Froelicher 21 Menopausal Hormone Therapy: Is There Evidence for Cardiac Protection? ...........................................................321 Nanette K. Wenger P IV. E P I ART CONOMICSAND OLICY SSUES H C R W IN EALTH ARE ELATED TO OMEN 22 Gender Bias: Is It Real and How Does It Affect Diagnosis, Management, and Outcome?....................................................351 Thomas H. Marwick and Jonathan Chan Contents ix 23 The Role of Women’s Health Centers in Improving Access and Process of Care..................................................................371 Susan Kendig and D. Douglas Miller 24 Obstetrician/Gynecologists, Primary Care, and Cardiovascular Disease .....................................................387 William W. Hurd, Sheela Barhan, and Robert E. Rogers 25 Health Technology Assessment in the Era of Managed Care: Issues in Women’s Health Care...............................................401 Laura Sampietro-Colom, Shawna Jackson, Erin Williams, and Frank J. Papatheofanis 26 Issues in the Analysis of Cost-Effectiveness in the Diagnosis and Treatment of Coronary Artery Disease in Women....................................................................413 Adam Atherly and Steven D. Culler Index...........................................................................................................................423 C ONTRIBUTORS ADAM ATHERLY,PhD, Department of Health Policy and Management, Rollins School of Public Health, Emory University, Atlanta, GA MICHAEL S. BAILEY,MD, Division of Cardiovascular Medicine, University of Florida, Gainesville, FL SHEELA BARHAN,MD,Department of Obstetrics and Gynecology, Wright State University School of Medicine, Dayton, OH ANDRA L. BLOMKALNS,MD, Department of Emergency Medicine, University of Cincinnati Medical Center, Cincinnati, OH PAUL R. CASPERSON,PhD, Division of Cardiology, University of Texas Health Science Center at San Antonio, TX JONATHAN CHAN,MBBS,Department of Medicine, University of Queensland, Brisbane, Australia ELISA YUEN MAN CHIU,RN,MS, Department of Physiological Nursing, School of Nursing, UCSF, San Francisco, CA STEVEN D. CULLER,PhD, Department of Health Policy and Management, Rollins School of Public Health, Emory University, Atlanta, GA ANNE B. CURTIS,MD, Division of Cardiovascular Medicine, University of Florida College of Medicine, Gainesville, FL CHRISTI DEATON,PhD,RN,FAHA, School of Nursing, Emory University, Atlanta, GA ERIKA SIVARAJAN FROELICHER,RN,PhD,FAAN, Department of Epidemiology and Biostatistics, School of Medicine, UCSF, San Francisco, CA W. BRIAN GIBLER,MD,Department of Emergency Medicine, University of Cincinnati Medical Center, Cincinnati, OH DARCY GREEN-CONAWAY,MD,Department of Cardiology, University of Missouri- Kansas City School of Medicine, Kansas City, MO WILLIAM W. HURD,MD,Department of Obstetrics and Gynecology, Wright State University School of Medicine, Dayton, OH SHAWNA JACKSON,MS, Aequitas Consulting Group, San Diego, CA ALICE K. JACOBS,MD,Evans Department of Medicine, Boston Medical Center, Boston, MA MARIELL JESSUP,MD,FACC,FAHA, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA B. DELIA JOHNSON,PhD,Epidemiology Data Center, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA SHERYL F. KELSEY,PhD,Epidemiology Data Center, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA SUSAN KENDIG,RNC,MSN,WHCNP,Barnes College of Nursing and Health Studies, University of Missouri-St. Louis, St. Louis, MO MARVIN A. KONSTAM,MD, Division of Cardiology, Department of Medicine, Tufts-New England Medical Center, Boston, MA CHERIE L. KUNIK,MSN,RN,CS,Shepherd Spinal Center, Atlanta, GA MICHAEL S. LAUER,MD,FACC, Department of Cardiology, Cleveland Clinic Foundation, Cleveland, OH xi xii Contributors JANE A. LEOPOLD,MD, Evans Department of Medicine, Boston Medical Center, Boston, MA THOMAS H. MARWICK,MD,PhD,FRACP,FACC, Department of Medicine, University of Queensland, Brisbane, Australia MICHAEL E. MENDELSOHN,MD,Molecular Cardiology Research Institute, Tufts-New England Medical Center, Boston, MA C. NOEL BAIREY MERZ,MD, Preventive and Rehabilitative Cardiac Center, Cedars Sinai Medical Center, Los Angeles, CA JENNIFER H. MIERES,MD,Division of Nuclear Medicine, North Shore University Hospital, Manhasset, NY D. DOUGLAS MILLER,MD,CM,MBA,FACC,FRCP(c), Department of Internal Medicine, Saint Louis University School of Medicine, St. Louis, MO DANIEL P. MORIN,MD,MPH, Division of Cardiology, Department of Medicine, Tufts-New England Medical Center, Boston, MA ANTHONY P. MORISE,MD, Section of Cardiology, Department of Medicine, West Virginia University School of Medicine, Morgantown, WV LORI MOSCA,MD,MPH,PhD,Division of Cardiology and Division of Preventive Medicine and Nutrition, New York-Presbyterian Hospital, Columbia and Cornell Universities, New York, NY SHARON MULVAGH,MD, Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN L. KRISTIN NEWBY,MD, Duke Clinical Research Institute, Duke University, Durham, NC ELIZABETH OFILI,MD, Division of Cardiology, Morehouse School of Medicine, Atlanta, GA ROBERT A. O’ROURKE,MD, Division of Cardiology, University of Texas Health Science Center at San Antonio, TX FRANK J. PAPATHEOFANIS,MD,MPH,PhD, Aequitas Consulting Group and Advanced Medical Technology Assessment and Policy Program, University of California, San Diego, CA ERIC PETERSON,MD,FACC, Duke Clinical Research Institute, Duke University, Durham, NC KIMBERLY J. RASK,MD,PhD,Division of General Internal Medicine, Emory University School of Medicine, and Department of Health Policy and Management, Rollins School of Public Health, Emory University, Atlanta, GA RITA F. REDBERG,MD,FACC, Department of Medicine, University of California School of Medicine, San Francisco, CA MARIA VIVINA T. REGIS,RN,MS,Department of Physiological Nursing, School of Nursing, University of California, San Francisco, CA VÉRONIQUE L. ROGER,MD,MPH, Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic and Foundation, Rochester, MN ROBERT E. ROGERS,MD, Department of Obstetrics and Gynecology, Indiana University School of Medicine, Indianapolis, IN JOHN A. RUMBERGER,PhD,MD,FACC, Division of Cardiology, Department of Medicine, The Ohio State University, Columbus, OH LAURA SAMPIETRO-COLOM,MD,MPH, Catalan Agency for Health Technology Assessment, Barcelona, Spain LESLEE J. SHAW,PhD,Outcomes Research, American Cardiovascular Research Institute, Atlanta, GA CLAIRE E. POTHIER SNADER,MA,Department of Cardiology, Cleveland Clinic Foundation, Cleveland, OH

See more

The list of books you might like

Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.